March 29, 2024 01:35 (IST)
ISSAR Pharma to out license its peptide-based New Chemical Entities
Hyderabad/IBNS: ISSAR Pharmaceuticals, a leading iIndian pharma company specialising in peptide technology and peptide drug innovation, announced they will license out their peptide-based New Chemical Entities (NCEs), with pre-IND filing and US Patent.
Latest Headlines
ISSAR Pharma to out license its peptide-based New Chemical Entities Tue, May 04 2021